7th European Biotech Crossroads presents international programme of top level conferences
25 September 2003 - 26 September 2003
France
Nantes, France, June 19, 2003 -- The seventh annual European Biotech Crossroads announces today a full programme of conferences for the event taking place on September 25-26. Key players from the world of biotechnology and more than 100 top level international experts will share their insights and experience in a series of conferences. The programme will enable visitors to compile their own à la carte menu of talks and conferences from the three main tracks of the Crossroads - science, business, and careers - alongside the trade show and business partnering convention.
The presence of government ministers and other European VIPs at the opening and closing ceremonies will highlight the important international status of the Crossroads. Claudie Haigneré, French minister for research and new technologies, will officially open Biotech Nantes 2003. Haigneré has invited Edelgard Buhlmahn, German minister for education and research and Philippe Busquin, European commissioner for research to open the event with her. Nicole Fontaine, French minister for industry has asked Lord Sainsbury of Turville, British parliamentary under-secretary of state for science and innovation and Erkki Liikanen, European commissioner for enterprise and information society to participate in the closing ceremony.
Full details of the conference programme including information on speakers can be found at http://www.biotech-nantes.com/programme.html.(opens in new window)
"We are delighted to have secured the participation of such excellent speakers for Biotech Nantes 2003," said Jean-François Balducchi, managing director at Atlanpole (Nantes-St Nazaire's technopole and bio-incubator) and Chairman of the 7th European Biotech Crossroads' Organising Committee. "As we put the finishing touches to the conference programme, we are more than satisfied that it further reinforces the convention's excellent international reputation. This conference programme demonstrates our commitment to make the European Biotech Crossroads a must for biotech people in Europe."
In putting together the programme of conferences and events, the convention's organisers have focused on addressing the hot issues affecting biotechnology today (such as nanotechnology, new diagnostics and analysis tools, and clinical trials), as well as tackling topics that have become more "traditional" (including gene therapy, genomics and proteomics, and vaccines). Organisers have also sought to make Biotech Nantes 2003 an original and unique event through interactive conferencing; information exchange has been made a priority over lectures, conference chairing will be lively, aided by real-life testimonials and case studies. The event organisers have spared no efforts to achieve a varied and complementary programme.
The conference programme including full list of speakers is given below. For a hard copy of the programme by mail or email, please contact Andrew Lloyd & Associates (e-mail: gilles@ala.com). Alternatively, you can download up-to-the-minute information at:,http://www.biotech-nantes.com/programme.html
About the European Biotech Crossroads, Biotech Nantes 2003:,http://www.biotech-nantes.com,The European Biotech Crossroads is one of the key annual events for biotechnology in Europe. Initiated in 1997 by the French Ministry of Research and organised in a different French city each year, the seventh European Biotech Crossroads will take place at the Cité des Congrès conference centre in Nantes, on September 25th and 26th, 2003. It will bring together all the key players in French and European biotech as well as a significant number of biotech companies from the rest of the world.
,The European Biotech Crossroads comprises:,* A two-day programme of world-class scientific seminars,* Europe's second biggest annual trade show for biotech professionals,* A business convention bringing together European investors, businesses, start-ups and specialised service providers such as lawyers and patent attorneys.
The 2002 Biotech Crossroads held in Lille brought together 3,208 delegates (35% of whom were from outside France, with 27 countries represented), 308 exhibitors at the trade show event and 180 participants in a business partnering convention which generated more than 1000 business meetings., ,The European Biotech Crossroads is organised by Atlanpole on behalf of the French Ministry of Research and New Technologies with support from the Pays de la Loire Regional Council, the Loire Atlantique General Council, Greater Nantes, the Brittany Regional Council, the Poitou Charentes Regional Council, the European Union, the Angers Development Agency, Nantes and Saint Nazaire Chamber of Commerce and Industry, ANVAR (the French Innovation Agency), Digitip (the French government's Directorate General for Industry and ICT), the French Ministry of Finance and Industry and INSERM Transfert.
The European Biotech Crossroads is organised in partnership with a number of official bodies: France Biotech (France's national biotech industry association), EuropaBio, ADEBIO (the French Association for the Development of Biotechnology and the Bioindustry), Génopole Ouest, France Technopoles Entreprises Innovation, EBN (European BIC Network), IASP (the International Association of Science Parks), CNRS (the French National Research Council for Scientific Research), Ifremer (the French Research Institute for Marine Studies), INRA (the French National Agronomic Research Council), Inserm, the France Atlantique university network, the University of Nantes, BioChim action, the Atlantic Innovation Relay Centre, Ouest Atlantique, and Alcimed.
About Atlanpole:,Atlanpole is a technopole, incubator and business innovation centre. It has been contributing to the company start-up process since 1987 and fuels the "Nantes Atlantique" business region's strong entrepreneurial spirit.
Given official recognition by the French Ministry of Research in 1999, the Atlanpole Bio-incubator has provided business support to more than 80 innovative start-up projects, including 32 in the life sciences.,Atlanpole draws on the experience of a multidisciplinary team serving entrepreneurs in three areas:,* Building and running a skills network,* Project engineering and innovation management,* Marketing the region and welcoming companies that choose it as a business location.
The presence of government ministers and other European VIPs at the opening and closing ceremonies will highlight the important international status of the Crossroads. Claudie Haigneré, French minister for research and new technologies, will officially open Biotech Nantes 2003. Haigneré has invited Edelgard Buhlmahn, German minister for education and research and Philippe Busquin, European commissioner for research to open the event with her. Nicole Fontaine, French minister for industry has asked Lord Sainsbury of Turville, British parliamentary under-secretary of state for science and innovation and Erkki Liikanen, European commissioner for enterprise and information society to participate in the closing ceremony.
Full details of the conference programme including information on speakers can be found at http://www.biotech-nantes.com/programme.html.(opens in new window)
"We are delighted to have secured the participation of such excellent speakers for Biotech Nantes 2003," said Jean-François Balducchi, managing director at Atlanpole (Nantes-St Nazaire's technopole and bio-incubator) and Chairman of the 7th European Biotech Crossroads' Organising Committee. "As we put the finishing touches to the conference programme, we are more than satisfied that it further reinforces the convention's excellent international reputation. This conference programme demonstrates our commitment to make the European Biotech Crossroads a must for biotech people in Europe."
In putting together the programme of conferences and events, the convention's organisers have focused on addressing the hot issues affecting biotechnology today (such as nanotechnology, new diagnostics and analysis tools, and clinical trials), as well as tackling topics that have become more "traditional" (including gene therapy, genomics and proteomics, and vaccines). Organisers have also sought to make Biotech Nantes 2003 an original and unique event through interactive conferencing; information exchange has been made a priority over lectures, conference chairing will be lively, aided by real-life testimonials and case studies. The event organisers have spared no efforts to achieve a varied and complementary programme.
The conference programme including full list of speakers is given below. For a hard copy of the programme by mail or email, please contact Andrew Lloyd & Associates (e-mail: gilles@ala.com). Alternatively, you can download up-to-the-minute information at:,http://www.biotech-nantes.com/programme.html
About the European Biotech Crossroads, Biotech Nantes 2003:,http://www.biotech-nantes.com,The European Biotech Crossroads is one of the key annual events for biotechnology in Europe. Initiated in 1997 by the French Ministry of Research and organised in a different French city each year, the seventh European Biotech Crossroads will take place at the Cité des Congrès conference centre in Nantes, on September 25th and 26th, 2003. It will bring together all the key players in French and European biotech as well as a significant number of biotech companies from the rest of the world.
,The European Biotech Crossroads comprises:,* A two-day programme of world-class scientific seminars,* Europe's second biggest annual trade show for biotech professionals,* A business convention bringing together European investors, businesses, start-ups and specialised service providers such as lawyers and patent attorneys.
The 2002 Biotech Crossroads held in Lille brought together 3,208 delegates (35% of whom were from outside France, with 27 countries represented), 308 exhibitors at the trade show event and 180 participants in a business partnering convention which generated more than 1000 business meetings., ,The European Biotech Crossroads is organised by Atlanpole on behalf of the French Ministry of Research and New Technologies with support from the Pays de la Loire Regional Council, the Loire Atlantique General Council, Greater Nantes, the Brittany Regional Council, the Poitou Charentes Regional Council, the European Union, the Angers Development Agency, Nantes and Saint Nazaire Chamber of Commerce and Industry, ANVAR (the French Innovation Agency), Digitip (the French government's Directorate General for Industry and ICT), the French Ministry of Finance and Industry and INSERM Transfert.
The European Biotech Crossroads is organised in partnership with a number of official bodies: France Biotech (France's national biotech industry association), EuropaBio, ADEBIO (the French Association for the Development of Biotechnology and the Bioindustry), Génopole Ouest, France Technopoles Entreprises Innovation, EBN (European BIC Network), IASP (the International Association of Science Parks), CNRS (the French National Research Council for Scientific Research), Ifremer (the French Research Institute for Marine Studies), INRA (the French National Agronomic Research Council), Inserm, the France Atlantique university network, the University of Nantes, BioChim action, the Atlantic Innovation Relay Centre, Ouest Atlantique, and Alcimed.
About Atlanpole:,Atlanpole is a technopole, incubator and business innovation centre. It has been contributing to the company start-up process since 1987 and fuels the "Nantes Atlantique" business region's strong entrepreneurial spirit.
Given official recognition by the French Ministry of Research in 1999, the Atlanpole Bio-incubator has provided business support to more than 80 innovative start-up projects, including 32 in the life sciences.,Atlanpole draws on the experience of a multidisciplinary team serving entrepreneurs in three areas:,* Building and running a skills network,* Project engineering and innovation management,* Marketing the region and welcoming companies that choose it as a business location.